Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by iHeartPodcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Closing Bell: Medtronic Gains, Merck Rises on Trial, Nvidia Faces Tech Weakness

5:52
 
Share
 

Manage episode 520110963 series 3654950
Content provided by iHeartPodcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Tim Stenovec and Carol Massar.

On this episode of Stock Movers:

- Medtronic (MDT) gained 4.6%, the biggest gainer in the S&P today. The rise came after the medical device maker lifted the bottom end of its range for adjusted profit forecast for the year. The company also boosted its organic revenue outlook following better-than-expected results in the second quarter.

- Merck (MRK) shares rose to their highest level since March after the drugmaker said a mid-stage trial of its drug for a rare form of high blood pressure met its main goal. Analysts see the trial win as a potential for an expanded market for the drug, Winrevair.

- Nvidia closed 2.8% lower. Tech weakness is persisting ahead of Nvidia's earnings report. The company, along with Microsoft, is committing to invest up to a combined $15 billion in Anthropic in a move that ties the AI developer closer to two of the biggest backers for its rival OpenAI.

See omnystudio.com/listener for privacy information.

  continue reading

1238 episodes

Artwork
iconShare
 
Manage episode 520110963 series 3654950
Content provided by iHeartPodcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Tim Stenovec and Carol Massar.

On this episode of Stock Movers:

- Medtronic (MDT) gained 4.6%, the biggest gainer in the S&P today. The rise came after the medical device maker lifted the bottom end of its range for adjusted profit forecast for the year. The company also boosted its organic revenue outlook following better-than-expected results in the second quarter.

- Merck (MRK) shares rose to their highest level since March after the drugmaker said a mid-stage trial of its drug for a rare form of high blood pressure met its main goal. Analysts see the trial win as a potential for an expanded market for the drug, Winrevair.

- Nvidia closed 2.8% lower. Tech weakness is persisting ahead of Nvidia's earnings report. The company, along with Microsoft, is committing to invest up to a combined $15 billion in Anthropic in a move that ties the AI developer closer to two of the biggest backers for its rival OpenAI.

See omnystudio.com/listener for privacy information.

  continue reading

1238 episodes

Все серии

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play